RECALL RECORD — CLASS IRecall closedF-1345-2019/FDA enforcement

El Guapo Chile Habanero Habanero Chili Pepper 0.5oz

What you need to know

Class I
  • What happened

    Mojave Foods Corporation (subsidiary of McCormick) is initiating a voluntary recall of El Guapo Chile Habanero and Chili Pasilla-Ancho pouches due to unlabeled peanut allergen.

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDAAL, AR, AZ, CA +24 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameMccormick & Company, INC. - Flavor Manufacturing Center
Recalling firmMccormick & Company, INC. - Flavor Manufacturing CenterHunt Valley, MD, United States
UPC / barcodes
0 44989 01296 8
Lot / date codes
  • UPC# 044989012968; Best By Apr/05/19; Best By; Jun/21/19; Best By Jun/22/19; Best By Oct/29/19
  • Best By Dec/07/19; Best By Feb/05/20; Best By Feb/06/20; Best By; Jun/12/20
Distribution area
ALARAZCACOFLGAIDILINIAKSKYMIMNMOMTNENVNMNCOHOKORTNTXUTWI

Product distributed to the following states: AL, AR, AZ, CA, CO, FL, GA, ID, IL, IN, IA, KS, KY, MI, MN, MO, MT, NE, NV, NM, NC, OH, OK, OR, TN, TX, UT, WI

United States

Quantity affected47, 044 pouches
Recall initiationFDA report date: May 15, 2019
FDA recall numberF-1345-2019

Beyond the headline

The recall, in context

Mccormick & Company, INC. - Flavor Manufacturing Center initiated this food recall on January 11, 2019. The FDA enforcement report states: Mojave Foods Corporation (subsidiary of McCormick) is initiating a voluntary recall of El Guapo Chile Habanero and Chili Pasilla-Ancho pouches due to unlabeled peanut allergen. The FDA report lists distribution as: Product distributed to the following states: AL, AR, AZ, CA, CO, FL, GA, ID, IL, IN, IA, KS, KY, MI, MN, MO, MT, NE, NV, NM, NC, OH, OK, OR, TN, TX, UT, WI.

The FDA enforcement report describes the reason as: Mojave Foods Corporation (subsidiary of McCormick) is initiating a voluntary recall of El Guapo Chile Habanero and Chili Pasilla-Ancho pouches due to unlabeled peanut allergen.

El Guapo Chile Habanero Habanero Chili Pepper 0.5oz was made or distributed by Mccormick & Company, INC. - Flavor Manufacturing Center in Hunt Valley, MD, United States. This page reflects FDA report F-1345-2019, dated May 15, 2019.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared peanut

Symptoms to watch for

Hives, swelling, wheezing, vomiting or anaphylaxis can occur in people with a peanut allergy.

When symptoms may appear

Reactions can begin within minutes to a few hours after eating the product.

Higher-risk groups

People with a diagnosed peanut allergy, especially children and anyone with a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a peanut allergy.
  2. 2Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the El Guapo Chile Habanero Habanero Chili Pepper 0.5oz recall?

Mccormick & Company, INC. - Flavor Manufacturing Center recalled El Guapo Chile Habanero Habanero Chili Pepper 0.5oz in an FDA Class I enforcement action reported as F-1345-2019. Mojave Foods Corporation (subsidiary of McCormick) is initiating a voluntary recall of El Guapo Chile Habanero and Chili Pasilla-Ancho pouches due to unlabeled peanut allergen.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Do not eat the product if you have a peanut allergy. Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis. Keep the packaging and contact the retailer or manufacturer about a refund.

Is the Mccormick & Company, INC. - Flavor Manufacturing Center recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-1345-2019. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Mccormick & Company, INC. - Flavor Manufacturing Center

View brand

Related alerts

Recent Other safety concern recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.